viewPhoto-Me International PLC

Photo-Me plans removal of 5000 photo booths and childrens rides as sales fall amid pandemic

Its Revolution laundry machines have been resilient, leading management to install 203 machines since May

Photo-Me International PLC -

Photo-Me International PLC (LON:PHTM) issued a profit warning as consumer demand for its vending equipment and services has remained “severely impacted” by the coronavirus pandemic.

With the Group's instant-service photo booths and children's rides typically situated in railway stations and shopping centres, the return of government lockdown restrictions and ongoing constraints on international travel have hurt the business after a “slight return” of consumer activity in the summer.

Group revenue for the six months to the end of October 2020 is expected to be down 26% on the same time last year with profit before tax for the 18-month period to end-October expected to be roughly £0.5mln.

However, the group said it was cash flow positive in the period and ended the period with a net cash balance of £22mln. It has agreed to new banking covenants to give it more flexibility, it added.

Revenue from photobooths has fallen 26% since the start of May while the smaller children's rides business was even more deeply affected.

However, its Revolution laundry machines have been resilient, with average revenue down just 2% compared with the same period last year, leading management to instal 203 machines since May.

In another effort at diversification, new “professional apple and pineapple juice machines” have been developed and are undergoing market testing with “promising results” in a number of locations across France and Belgium.

Furthermore, directors plan to reduce the number of photo booths by around 17%, with almost 5,000 unprofitable photobooths and children's rides being sold or scrapped across the UK, Europe, China and South Korea.

Quick facts: Photo-Me International PLC

Price: 50.4 GBX

Market: AIM
Market Cap: £190.52 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Allergy Therapeutics reveal 'remarkable' growth given 'challenges...

Allergy Therapeutics PLC's (LON:AGY) CFO Nick Wykeman and CEO Manuel Llobet join Proactive London's Katie Pilbeam to discuss their record profits for the six-month stage, with revenues up 7% at £54mln for the half to December 31. The group also posted pre-R&D operating income of £20.5mln,...

3 minutes ago

2 min read